CurveBeam AI Limited (ASX:CVB)

Market Cap	51.40M
Revenue (ttm)	12.10M
Net Income (ttm)	-16.84M
Shares Out	395.40M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,288
Average Volume	106,108
Open	0.1250
Previous Close	0.1300
Day's Range	0.1250 - 0.1250
52-Week Range	0.0650 - 0.1825
Beta	1.74
RSI	50.95
Earnings Date	Aug 29, 2025

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America and internationally. The company provides orthopedic products, such as HiRise for bilateral weight bearing CT imaging; LineUP for bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lowe...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 50
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CVB

Financial Performance

In 2025, CurveBeam AI's revenue was 12.10 million, an increase of 85.33% compared to the previous year's 6.53 million. Losses were -16.84 million, -27.09% less than in 2024.